• DFO (9H-1,8-Diazafluoren-9-one): Optimizing Latent Fingerpri

  2026-05-24

  DFO (9H-1,8-Diazafluoren-9-one) streamlines latent fingerprint visualization on porous substrates, delivering superior sensitivity and clarity for forensic labs. This guide details evidence-based workflows, troubleshooting strategies, and cross-study insights that maximize detection reliability with APExBIO's high-purity DFO.

• Pomalidomide (CC-4047): Mutational Landscape and Precision i

  2026-05-23

  Explore how Pomalidomide (CC-4047) empowers precision research in multiple myeloma through actionable insights into cellular heterogeneity and drug resistance. This article uniquely integrates mutational landscape analysis with advanced assay strategies.

• Imatinib (STI571): New Insights in Tyrosine Kinase Pathway R

  2026-05-22

  Discover how Imatinib (STI571) advances signal transduction research and cancer biology by integrating breakthrough findings in erythroid differentiation and kinase pathway inhibition. Explore distinct, practical guidance for leveraging Imatinib in complex cellular models.

• PERK-Dependent JAK1–STAT3 Drives Pyroptosis in Disc Cells

  2026-05-22

  This study reveals that endoplasmic reticulum stress (ERS) promotes pyroptosis and inflammation in nucleus pulposus cells through PERK-dependent activation of JAK1–STAT3 signaling, elucidating a critical pathway in intervertebral disc degeneration. The findings highlight new molecular targets for modulating cell death and inflammation in degenerative disc disease.

• ONX-0914 (PR-957): Precision Immunoproteasome Inhibition in

  2026-05-21

  ONX-0914 (PR-957) is redefining immunoproteasome inhibition with unprecedented selectivity, enabling researchers to dissect cytokine-driven disease mechanisms with clarity. This article details protocol enhancements, troubleshooting, and practical workflow integration, spotlighting the latest mechanistic insights for autoimmune, inflammatory, and airway disease models.

• CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E

  2026-05-21

  A recent study has revealed CLCC1 as an essential host protein mediating membrane fusion during herpesvirus nuclear egress, advancing our understanding of viral replication. By employing a genome-wide CRISPR screen, the work highlights both mechanistic insights and potential avenues for targeting host-virus interactions.

• Ranolazine: Mechanistic Leverage for Translational Cardiac R

  2026-05-20

  This article explores how Ranolazine’s dual modulation of sodium currents and metabolic pathways is transforming translational research in cardiac ischemia. By integrating mechanistic insights, protocol guidance, and recent findings on immune-metabolic crosstalk, we offer actionable strategies for researchers seeking robust, clinically relevant models and data.

• Analytical Approaches for Rotigotine: Purity, Stability, and

  2026-05-20

  This review synthesizes advances in analytical methodologies for assessing rotigotine purity, stability, and impurity profiles in both raw material and transdermal pharmaceutical formulations. The paper highlights robust chromatographic techniques and regulatory perspectives, providing a foundation for future quality control and formulation development in Parkinson’s disease research.

• COG133 Peptide Modulates miRNA146a in Diabetic Fibroblasts

  2026-05-19

  This study demonstrates that the ApoE-mimetic peptide COG133 promotes wound-healing mechanisms in human diabetic fibroblasts by upregulating miRNA146a and reducing pro-inflammatory signaling. The peptide also exhibits notable antibacterial and antibiofilm activity, highlighting its translational potential for diabetic wound management.

• Maraviroc (UK-427857): Bridging HIV-1 Entry Inhibition and N

  2026-05-19

  Discover how Maraviroc (UK-427857) serves as a powerful research tool for dissecting CCR5-mediated HIV-1 entry inhibition and neuroinflammation modulation. This article delivers a unique, in-depth exploration of Maraviroc’s mechanistic role, experimental considerations, and translational prospects, setting it apart from prior guides.

• CCK-8s Induces ANP Secretion via NOX4–PGC-1α–PPAR Signaling

  2026-05-18

  This study uncovers how sulfated cholecystokinin octapeptide (CCK-8s) promotes atrial natriuretic peptide (ANP) secretion in isolated rat atria through activation of NOX4–PGC-1α–PPARα/PPARγ signaling. The findings add to our understanding of cardiovascular hormone regulation and provide a mechanistic link between oxidative signaling, cardiac peptide secretion, and atrial function.

• 3-Deazaneplanocin (DZNep): Applied Workflows in Epigenetic M

  2026-05-18

  3-Deazaneplanocin (DZNep) from APExBIO empowers researchers to dissect epigenetic regulation and target cancer stem cells with precision. This guide delivers actionable protocols, troubleshooting strategies, and critical insights for maximizing DZNep’s impact in cancer and metabolic disease models.

• ATRX Loss Sensitizes Glioma Cells to RTK and PDGFR Inhibitor

  2026-05-17

  The referenced study reveals that high-grade glioma cells lacking ATRX are significantly more sensitive to receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors than ATRX-proficient counterparts. This finding supports stratifying patients by ATRX status in future therapeutic trials and highlights new avenues for targeted glioma treatment.

• Quinolone–Coumarin Hybrids and Novobiocin in T. gondii Inhib

  2026-05-16

  This study demonstrates that select quinolone–coumarin hybrids, synthesized from fluoroquinolones and Novobiocin, show potent and selective antiparasitic activity against Toxoplasma gondii in vitro. The findings highlight new chemical leads with improved selectivity over current treatments, supporting further development of aminocoumarin antibiotic derivatives for antiparasitic research.

• In Vitro Pharmacodynamics of Gamithromycin vs. MmmSC: Method

  2026-05-15

  This study evaluates the in vitro activity of gamithromycin and older macrolides against Mycoplasma mycoides subsp. mycoides Small Colony (MmmSC), the agent of contagious bovine pleuropneumonia. Through detailed pharmacodynamic analysis, the research clarifies efficacy profiles and post-antibiotic effects, informing antibiotic selection for veterinary pathogen control.

450 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page